CLDN6 CAR-T clinical trials

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

This study is testing a new cell therapy and a vaccine for people with advanced solid tumors. It aims to find out how safe they are and if they can help shrink tumors that have a specific marker called CLDN6.